Effect of increased concentration of D-glucose or L-fucose on monocyte adhesion to endothelial cell monolayers and activation of nuclear factor-[kappa ]B
Published in
Metabolism: Clinical and Experimental, February 2002
Increased adhesion of monocytes to endothelial cells has been linked to the development and progression of atherosclerosis in humans with diabetes. Previous studies have shown that increased concentration of glucose and subsequent generation of reactive oxygen species and the activation of the transcription factor nuclear factor-kappaB (NF-kappaB) may mediate this response. However, our studies have shown that in addition to glucose, other monosaccharides, such as L-fucose, which is increased in circulation in diabetes, may also contribute to the development of diabetic complications. In these studies, we examined the effect of an increased concentration of L-fucose on monocyte adhesion to cultured bovine aorta endothelial cells. Exposing cultured bovine aorta endothelial cells to an increased concentration of either glucose or L-fucose caused a concentration-dependent increase in adhesion of monocytes. The increase in monocyte adhesion induced by glucose or L-fucose was preceded by the activation to NF-kappaB and the generation of reactive oxygen species. The combination of glucose and L-fucose at a submaximal concentration did not appear to have an additive effect on the induction of monocyte adhesion. The addition of alpha-lipoic acid partially prevented the glucose and L-fucose-induced activation of NF-kappaB, generation of reactive oxygen species, and increase in monocyte adhesion. This suggests that the effect of an increased concentration of glucose or L-fucose on monocyte adhesion to endothelial cells is at least partially due to the production oxygen-derived free radicals. Furthermore, these studies provide evidence that monosaccharides other than glucose that are increased in the circulation of humans with diabetes may contribute to vascular defects in diabetes.
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2010.
All research outputs
#12,344,996
of 34,363,559 outputs
Outputs from Metabolism: Clinical and Experimental
#2,004
of 4,589 outputs
Outputs of similar age
#59,566
of 185,382 outputs
Outputs of similar age from Metabolism: Clinical and Experimental
#8
of 21 outputs
Altmetric has tracked 34,363,559 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,589 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 185,382 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
